Telangana DCA Made 54 Seizures Worth Rs 19.35 Lakh In September

Hyderabad: In a major crackdown, the Telangana Drugs Control Administration (DCA) conducted 54 seizures in September, confiscating medicine stocks worth Rs 19.35 lakh.

Of these, 26 cases involved quacks engaged in unlicensed stocking and sale of drugs, while 14 relate to drugs being falsely marketed as food products or nutraceuticals. Additionally, nine raids targeted unlicensed medical shops and godowns, three focused on expired drugs, and one each involved licensed manufacturing violations and banned drugs.

Among the key raids are an operation that took place on September 4, when DCA officials seized medicines worth ₹ 4 lakh from an unlicensed godown in Sangareddy. Later, on September 18, the DCA busted an illegal sale of steroid drugs intended for gym-goers involved in bodybuilding in Hyderabad. Authorities seized steroid medicines worth ₹2 lakh, which were being sold without a valid drug licence.

The Telangana Drugs Control Administration issues drug licences to medical shops and pharmacies under the Drugs and Cosmetics Act, and selling or stocking drugs without a licence can result in imprisonment of up to five years, a release stated.

A review of the DCA’s operations from January 1 to September 30 reveals that during this period, 132 cases were booked for misleading advertisements, 92 cases targeted quacks involved in unlicensed drug sales, and 72 cases were related to price violations under the Drugs (Prices Control) Order. Other cases included 49 for unlicensed drug manufacturing, 34 for marketing drugs as food products or nutraceuticals, six for spurious drug rackets, five for unlicensed cosmetic manufacturing, three for banned drug sales, and one case involving misbranded cosmetics.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’